FeesSafety
Pluang+

Concentrix earns top Everest Group rankings for AI-driven fraud, compliance, and trust services in 2026

Market News
29 Oct 2026, 16:01 WIB
GlobeNewsWire
View Source
Bullish
Concentrix earns top Everest Group rankings for AI-driven fraud, compliance, and trust services in 2026

Concentrix Corporation has been recognized by Everest Group as a leader in four critical business areas: fraud management, financial crime and compliance, trust and safety, and agentic operations. This recognition highlights Concentrix's innovative use of AI and strategic partnerships to help clients manage emerging risks and regulatory challenges. The company’s recent acquisition of CastleHill Managed Risk Solutions has expanded its capabilities in governance and AI governance, supporting long-term client growth. These accolades affirm Concentrix’s role in integrating human and AI solutions to build trust and operational resilience in a rapidly evolving business environment.

Concentrix's recognition in AI-driven fraud and risk management is the context for this Technology-sector market snapshot on Pluang. As of Oct 29, 2026 19:13 WIB, 21 of 150 priced Technology-sector US stocks rose while 127 fell. Notable movers include AXTI at USD 59.48 with a 7.61% decline, ZS at USD 236.40 down 7.58%, and NBIS at USD 169.30 down 7.15%.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App